NCT01427816View on ClinicalTrials.gov

A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

Not specified

Conditions
Dry Eye Syndromes
Interventions
DRUG

KCT-0809

DRUG

KCT-0809

DRUG

Placebo

Trial Locations (1)

Unknown

Japan, Tokyo and Other Japanese City

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY

NCT01427816 - A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome | Biotech Hunter | Biotech Hunter